Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graeme W Carlile

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Blood|February 21, 2004
Caspase-3 has a nonapoptotic function in erythroid maturationGraeme W Carlile, Deborah H Smith, Martin Wiedmann
FEBS Letters|February 27, 2009
A non-apoptotic role for Fas/FasL in erythropoiesisGraeme W Carlile, Deborah H Smith, Martin Wiedmann
Expert Opinion on Therapeutic Targets|June 7, 2019
Cystic Fibrosis: Proteostatic correctors of CFTR trafficking and alternative therapeutic targetsJohn W Hanrahan, Yukiko Sato, Graeme W Carlile, et al.
Chemistry & Biology|February 23, 2011
Identification of a NBD1-binding pharmacological chaperone that corrects the trafficking defect of F508del-CFTRHeidi M Sampson, Renaud Robert, Jie Liao, et al.
Chembiochem : a European Journal of Chemical Biology|May 15, 2007
Correctors of protein trafficking defects identified by a novel high-throughput screening assayGraeme W Carlile, Renaud Robert, Donglei Zhang, et al.
ACS Omega|October 19, 2020
Combination of Selective PARP3 and PARP16 Inhibitory Analogues of Latonduine A Corrects F508del-CFTR TraffickingRyan M Centko, Graeme W Carlile, Isabel Barne, et al.
American Journal of Physiology. Cell Physiology|September 19, 2022
Chronic obstructive pulmonary disease and the modulation of CFTR by acute exposure to cigarette smokeJohn W Hanrahan, Asmahan Abu-Arish, Francis H Wong, et al.
British Journal of Pharmacology|October 24, 2015
Low free drug concentration prevents inhibition of F508del CFTR functional expression by the potentiator VX-770 (ivacaftor)Elizabeth Matthes, Julie Goepp, Graeme W Carlile, et al.
Scientific Reports|August 1, 2018
A novel triple combination of pharmacological chaperones improves F508del-CFTR correctionGraeme W Carlile, Qi Yang, Elizabeth Matthes, et al.
Molecular Pharmacology|November 3, 2007
Structural analog of sildenafil identified as a novel corrector of the F508del-CFTR trafficking defectRenaud Robert, Graeme W Carlile, Catalin Pavel, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Blood|February 21, 2004
Caspase-3 has a nonapoptotic function in erythroid maturationGraeme W Carlile, Deborah H Smith, Martin Wiedmann
FEBS Letters|February 27, 2009
A non-apoptotic role for Fas/FasL in erythropoiesisGraeme W Carlile, Deborah H Smith, Martin Wiedmann
Expert Opinion on Therapeutic Targets|June 7, 2019
Cystic Fibrosis: Proteostatic correctors of CFTR trafficking and alternative therapeutic targetsJohn W Hanrahan, Yukiko Sato, Graeme W Carlile, et al.
Chemistry & Biology|February 23, 2011
Identification of a NBD1-binding pharmacological chaperone that corrects the trafficking defect of F508del-CFTRHeidi M Sampson, Renaud Robert, Jie Liao, et al.
Chembiochem : a European Journal of Chemical Biology|May 15, 2007
Correctors of protein trafficking defects identified by a novel high-throughput screening assayGraeme W Carlile, Renaud Robert, Donglei Zhang, et al.
ACS Omega|October 19, 2020
Combination of Selective PARP3 and PARP16 Inhibitory Analogues of Latonduine A Corrects F508del-CFTR TraffickingRyan M Centko, Graeme W Carlile, Isabel Barne, et al.
American Journal of Physiology. Cell Physiology|September 19, 2022
Chronic obstructive pulmonary disease and the modulation of CFTR by acute exposure to cigarette smokeJohn W Hanrahan, Asmahan Abu-Arish, Francis H Wong, et al.
British Journal of Pharmacology|October 24, 2015
Low free drug concentration prevents inhibition of F508del CFTR functional expression by the potentiator VX-770 (ivacaftor)Elizabeth Matthes, Julie Goepp, Graeme W Carlile, et al.
Scientific Reports|August 1, 2018
A novel triple combination of pharmacological chaperones improves F508del-CFTR correctionGraeme W Carlile, Qi Yang, Elizabeth Matthes, et al.
Molecular Pharmacology|November 3, 2007
Structural analog of sildenafil identified as a novel corrector of the F508del-CFTR trafficking defectRenaud Robert, Graeme W Carlile, Catalin Pavel, et al.
Pageof 3